More recently, researchers have also focused on understanding the relevance of APOE ε4 prevalence and the early stages of cognitive impairment, such as subjective cognitive decline (SCD), which is an intermediate stage between mild cognitive impairment (MCI) and normal cognition. The gene discussed is APOE; the disease is Cognitive impairment.